PadelettiL, ArnarDO, BoncinelliLet al.EHRA Expert Consensus Statement on the management of cardiovascular implantable electronic devices in patients nearing end of life or requesting withdrawal of therapy. Europace, 2010; 12,10:1480–1489.
2.
MarinskisG, van ErvenL. Deactivation of implanted cardioverter-defibrillators at the end of life: Results of the EHRA survey. Europace, 2010; 12,8:1176–1177.
3.
GoldsteinN, CarlsonM, LivoteE, KutnerJS. Brief communication: Management of implantable cardioverter-defibrillators in hospice: A nationwide survey. Ann Intern Med, 2010; 152,5:296–299.
4.
MahoneyFI, BarthelDW. Functional Evaluation: The Barthel Index. Md State Med J, 1965; 14:61–65.
5.
KramerDB, OttenbergAL, GerhardsonSet al.“Just because we can doesn't mean we should:” Views of nurses on deactivation of pacemakers and implantable cardioverter-defibrillators. J Interv Card Electrophysiol, 2011; 30:30.
